Annual Cash & Cash Equivalents
$34.62 M
-$19.16 M-35.63%
March 31, 2024
Summary
- As of February 8, 2025, LSB annual cash & cash equivalents is $34.62 million, with the most recent change of -$19.16 million (-35.63%) on March 31, 2024.
- During the last 3 years, LSB annual cash & cash equivalents has fallen by -$24.70 million (-41.64%).
- LSB annual cash & cash equivalents is now -41.64% below its all-time high of $59.32 million, reached on March 1, 2021.
Performance
LSB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$7.05 M
-$28.57 M-80.20%
September 1, 2024
Summary
- As of February 8, 2025, LSB quarterly cash and cash equivalents is $7.05 million, with the most recent change of -$28.57 million (-80.20%) on September 1, 2024.
- Over the past year, LSB quarterly cash and cash equivalents has stayed the same.
- LSB quarterly cash and cash equivalents is now -83.45% below its all-time high of $42.64 million, reached on March 1, 2022.
Performance
LSB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LSB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.6% | 0.0% |
| 3 y3 years | -41.6% | 0.0% |
| 5 y5 years | -41.6% | 0.0% |
LSB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.6% | at low | -83.5% | at low |
| 5 y | 5-year | -41.6% | at low | -83.5% | at low |
| alltime | all time | -41.6% | at low | -83.5% | at low |
LakeShore Biopharma Co Ltd Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.05 M(-80.2%) |
| Mar 2024 | $34.62 M(-35.6%) | - |
| Sep 2023 | - | $35.62 M(+172.7%) |
| Jun 2023 | - | $13.06 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | $53.78 M(+26.1%) | - |
| Sep 2022 | - | $31.82 M(-25.4%) |
| Mar 2022 | $42.64 M(-28.1%) | $42.64 M |
| Mar 2021 | $59.32 M | - |
FAQ
- What is LakeShore Biopharma Co Ltd annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd annual cash & cash equivalents year-on-year change?
- What is LakeShore Biopharma Co Ltd quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd quarterly cash and cash equivalents year-on-year change?
What is LakeShore Biopharma Co Ltd annual cash & cash equivalents?
The current annual cash & cash equivalents of LSB is $34.62 M
What is the all time high annual cash & cash equivalents for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high annual cash & cash equivalents is $59.32 M
What is LakeShore Biopharma Co Ltd annual cash & cash equivalents year-on-year change?
Over the past year, LSB annual cash & cash equivalents has changed by -$19.16 M (-35.63%)
What is LakeShore Biopharma Co Ltd quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LSB is $7.05 M
What is the all time high quarterly cash and cash equivalents for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high quarterly cash and cash equivalents is $42.64 M
What is LakeShore Biopharma Co Ltd quarterly cash and cash equivalents year-on-year change?
Over the past year, LSB quarterly cash and cash equivalents has changed by $0.00 (0.00%)